chronic kidney disease with hyperkalaemia
Endocrinology · 2020–2020
1decision
1medicine
1carried consumer input
1individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| patiromer Initial treatment of patients with chronic kidney disease (CKD) Stage 3 or 4, with chronic hyperkalaemia (>1 episode of serum K+ ≥6.0 mmol/L in the previous 12… | Nov 2020 | Not recommended | 1 individuals |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.